View the AGAT TIMES and subscribe below.
For more information about AGAT Laboratories' community involvement programs, please email:
Fentanyl related deaths in Alberta have exploded in recent years and have quickly become a major health crisis, especially for youth. While fentanyl has made headlines, currently there are limited resources available to educate students on both the medical applications and risks when abused as a recreational drug. A presentation was delivered at the Calgary City Teachers' Convention by a doctor, police detective and clinical professor who provided the medical background and hard facts on fentanyl. They shared first hand experiences of fentanyl use and abuse that they have witnessed in their professional fields. They provided resources available to support teachers in informing students on the dangers of fentanyl and how to help those with addiction.
The topics are:
1. Cybercrime Education2. Drug Awareness (including fentanyl abuse)3. Graffiti
Agat Laboratories recently contributed to help fund the research studies of Dr. Robert Maggisano and his colleagues, Dr. Andrew check and Dr. Giuseppe Papia, in vascular and Diabetic limb Saving Centre in Toronto . AGAT Laboratories and John DeSanti, Executive Chairman, will be working closely with Dr. Maggisano to assist with future funding and the creation of a Chair at the university of Toronto for continuing and expanded research. Dr Maggisano's work over the years has saved many lives and the continuation of this dedication makes for proud association for AGAT Laboratories.
Sunnybrook vascular surgeons have become Canadian leaders in vascular care, and in particular Endovascular therapies. They are transforming vascular care in Canada and making a difference now.
Our efforts have been the catalyst in securing the University of Toronto/Sunnybrook endowed chair in vascular surgery for Dr. Maggisano, so that he could continue with the development, evaluation, and education of less invasive image-guided vascular interventions. He has now partnered with the Sunnybrook Schulich programme's cardiologists and cardiac surgeons, to capitalize on synergies and extend his vision of expanding the infrastructure, research, and educational activities to position the Sunnybrook Vascular group as a recognized leader internationally.
(In the middle: John Desanti, Executive Chairman, AGAT Laboratories)
(Certificate of Appreciation)
Patients with chronic diabetes or advanced vascular disease can develop painful leg ulcers and even with treatment 40% still progress to requiring major amputation. Diabetes affects almost 10% of the population of Ontario and is rising. Complications of diabetes will affect tens of thousands of Ontarians yearly. There are over 2000 amputations per year in Ontario due to diabetes, all of which result in significant disability, decreased quality of life and cost to both the patient and the system. With increasing rates of diabetes, the number of patients suffering amputations per year will increase by 50% over the next 20 years.
What’s wrong with the care currently available?
To prevent major amputations a combination of treatments is needed. Early recognition and coordinated treatment with multiple types of therapy including medications, wound care, and potentially rebuilding damaged arteries with stents or surgery are all required. Unfortunately, because these treatments are traditionally delivered by a variety of specialists in different physical locations at different times, getting the timing of coordinating treatment right is very difficult. The result is unnecessary admissions to hospital, or even amputation. An enormous burden falls to patients to self-diagnose, research and manage their own care.
What can we do about it?
The team at Sunnybrook has already achieved local, provincial and national recognition for their work in this area utilizing existing infrastructure. Current demand is outstripping their capacity.
They want to create a single outpatient centre outside of the hospital where all testing, physician appointments and treatments will occur. Their mission is to provide care that is complete, cutting edge, innovative and convenient for patients to access. The centre will promote early detection and diagnosis of wounds and aggressive treatments, which will reduce the rate of amputation from 40% to 5%. It’s like a cancer centre for patients facing amputation, and although there are some in Europe and the United States, none exist in Canada. The support of the public is critical as they continue working with our community and ministry partners to build the centre.
AGAT Laboratories Ltd. © 2011
Please select one or more sector areas you would be interested in learning about: